Note that by definition, as these things you mention progress the DCF valuation will also progress in line with them, as a DCF already contains discounts for these future events that haven't happened yet.So this progression of events is not guaranteed to close the share price DCF gap. In fact it may increase the gap further.
The Whens and Whys of Top Biotech M&A Deals, page-45
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.21 |
Change
-0.270(1.74%) |
Mkt cap ! $1.944B | |||
| Open | High | Low | Value | Volume |
| $15.20 | $15.33 | $15.02 | $8.268M | 543.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 700 | $15.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.24 | 220 | 1 |
View Market Depth
| Last trade - 16.10pm 22/08/2024 (20 minute delay) ? |
| NEU (ASX) Chart |